Danaher Life Sciences — Segment Reporting, Other Segment Item, Amount increased by 12.2% to $1.54B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $1.46B to $1.54B. Over 3 years (FY 2022 to FY 2025), Life Sciences — Segment Reporting, Other Segment Item, Amount shows relatively stable performance with a 3.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High or increasing values may indicate ongoing restructuring or integration challenges within the segment.
Represents miscellaneous operational costs or adjustments specific to the Life Sciences segment that do not fall into st...
Varies significantly by company; peers may categorize these as 'other operating expenses' or 'special items'.
dhr_segment_life_sciences_segment_reporting_other_segment_item_amount| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.27B | $1.27B | $1.27B | $1.27B | $1.34B | $1.34B | $1.34B | $1.34B | $1.33B | $1.36B | $1.33B | $1.46B | $1.29B | $1.39B | $1.37B | $1.54B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.6% | +0.0% | +0.0% | +0.0% | -0.9% | +1.9% | -1.6% | +9.7% | -12.2% | +8.1% | -1.4% | +12.2% |
| YoY Change | — | — | — | — | +5.6% | +5.6% | +5.6% | +5.6% | -0.9% | +0.9% | -0.7% | +9.0% | -3.5% | +2.4% | +2.6% | +4.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.